Rochester, NY 8/19/2009 8:11:52 PM
Geron Corporation GERN - Market Updates on Financial Stock – Clinical Hold Geron's Shares Down
Geron Corporation GERN
Geron Corporation makes an announcement that clinical hold is driving Geron's shares lower, down ten and a half percent to $6.47.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Geron Corporation announced that its Investigational New Drug application for a cell therapy of neurologically complete, sub-acute spinal cord injury has been placed on clinical hold by the FDA. A clinical hold is an order that the FDA issues to a sponsor to delay a proposed trial or to suspend an ongoing trial.
StockEinstein.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
